The efficacy of erythropoietin in human immunodeficiency virus—infected end-stage renal disease patients treated by maintenance hemodialysis
- 30 June 1995
- journal article
- research article
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 25 (6), 904-909
- https://doi.org/10.1016/0272-6386(95)90573-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Erythropoietin and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Levels in Sera of Patients with HIV InfectionInternational Journal of STD & AIDS, 1991
- Pathophysiology and management of HIV-associated hematologic disordersBlood, 1989
- The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietinKidney International, 1989
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Haematologic manifestations of the human immune deficiency virus (HIV)British Journal of Haematology, 1987
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- Anemia of end-stage renal disease (ESRD)Kidney International, 1985
- Hematologic abnormalities in the acquired immune deficiency syndromeAmerican Journal Of Medicine, 1984
- Mechanism of the Anemia of Chronic Renal FailureNephron, 1980
- Inhibition of Cell Proliferation in Renal Failure and its Significance to the Uraemic Syndrome: A ReviewScottish Medical Journal, 1975